Learn Quant Trading | QuantStrategy.io Learn Quant Trading | QuantStrategy.io
  • Categories
  • Features
    • Category Blocks
    • Content Blocks
      • Accordions
      • Alerts
      • Author
      • Facebook Fanpage
      • Instagram Feed
      • Pinterest Board
      • Progress Bars
      • Separators
      • Share Buttons
      • Social Links
      • Subscription Forms
      • Tabs & Pills
      • Twitter Feed
    • Content Formatting
      • Badges
      • Drop Caps
      • Styled Blocks
      • Styled Lists
      • Numbered Headings
    • Gallery Blocks
    • Promo Blocks
    • Inline Posts
    • Contact Form
  • Sample Page
  • Buy Now

Categories

  • Alpha Lab
  • Book Bites
  • Candlestick Patterns
  • Chart Patterns
  • Crypto Currencies
  • Custom Indicators
  • Custom Strategies
  • Famous Traders
  • Futures Trading
  • ML And AI Models
  • Options Trading
  • Stocks and ETFs
  • Strategy Backtesting
  • Strategy Filters
  • Technical Indicators
  • Theme Investing
  • Trading Psychology
  • Trading Strategies
Learn Quant Trading | QuantStrategy.io Learn Quant Trading | QuantStrategy.io
Follow
Learn Quant Trading | QuantStrategy.io Learn Quant Trading | QuantStrategy.io
  • Home
  • About Us

Browsing Category

Stocks and ETFs

190 posts

Go beyond the ticker symbol. Here, we break down the mechanics of Stock and ETF trading, focusing on technical setups, sector rotation, and risk management. Discover how to pick high-momentum stocks and leverage thematic ETFs to capitalize on the 2026 market’s biggest trends. Turn market data into actionable trade ideas.

SStocks and ETFs
Read More
  • 5 minute read

Top 5 Fitness ETFs to Watch as GLP-1 Adoption Scales Globally

  • byQuantStrategy.io Team
  • May 6, 2026
The global healthcare landscape is undergoing a seismic shift as glucagon-like peptide-1 (GLP-1) receptor agonists, originally designed for…
SStocks and ETFs
Read More
  • 6 minute read

Planet Fitness and the GLP-1 Thesis: Why Low-Cost Gyms Might Win Big

  • byQuantStrategy.io Team
  • May 6, 2026
The rise of weight loss medications like Ozempic, Wegovy, and Mounjaro has sparked a massive debate in the…
TTechnical Indicators
Read More
  • 6 minute read

Technical Analysis of Planet Fitness (PLNT) Stock in a New Healthcare Era

  • byQuantStrategy.io Team
  • May 6, 2026
The investment landscape for fitness stocks has undergone a seismic shift as weight loss medications like Ozempic and…
SStocks and ETFs
Read More
  • 8 minute read

Investing in the Future of Cardiovascular Health: GLP-1 Breakthroughs and the Downstream Cardiac Care Market

  • byQuantStrategy.io Team
  • May 5, 2026
The landscape of global healthcare is currently undergoing a seismic shift, driven by the unprecedented success of Glucagon-like…
SStocks and ETFs
Read More
  • 6 minute read

GLP-1 Impact on Food and Beverage Stocks: Navigating the Shift in Consumer Behavior

  • byQuantStrategy.io Team
  • May 5, 2026
The rise of GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro is no longer just a pharmaceutical phenomenon;…
SStocks and ETFs
Read More
  • 8 minute read

The GLP-1 Revolution: Analyzing the Multi-Sector Impact on Healthcare, Food, and Medical Device Stocks

  • byQuantStrategy.io Team
  • May 5, 2026
The rise of Glucagon-like peptide-1 (GLP-1) receptor agonists represents more than just a medical breakthrough in treating type…
TTrading Strategies
Read More
  • 6 minute read

Trading the ‘Ozempic Economy’: A Guide to Fitness and Wellness Stocks

  • byQuantStrategy.io Team
  • May 5, 2026
The financial landscape is currently undergoing a seismic shift driven by the meteoric rise of GLP-1 receptor agonists…
AAlpha Lab
Read More
  • 5 minute read

How GLP-1 Heart Disease Clinical Trials are Reshaping Biotech Portfolios

  • byQuantStrategy.io Team
  • May 4, 2026
The landscape of biotechnology investing is undergoing a tectonic shift driven by the expansion of glucagon-like peptide-1 (GLP-1)…
SStocks and ETFs
Read More
  • 6 minute read

Medical Device Companies Under Pressure: The GLP-1 Threat to Traditional Treatments

  • byQuantStrategy.io Team
  • May 4, 2026
The healthcare landscape is undergoing a seismic shift as glucagon-like peptide-1 (GLP-1) receptor agonists, originally designed for type…
SStrategy Backtesting
Read More
  • 6 minute read

How to Backtest a Biotech Portfolio: GLP-1 Sector Performance Analysis

  • byQuantStrategy.io Team
  • May 4, 2026
Investing in the pharmaceutical sector, specifically within the rapidly evolving weight loss market, requires a blend of fundamental…
Learn Quant Trading | QuantStrategy.io Learn Quant Trading | QuantStrategy.io
Disclaimer | Blog | About | Pricing | Contact Us | Privacy | Terms
0
0
0
0
30
0
0